Delisted
This security is no longer actively traded. Historical data is preserved for reference.No holders in 2026-Q1, no recent price data
RAPT THERAPEUTICS INC
RAPT·75382E208·US·Common Stock·Healthcare - Biotechnology-13D/G
RAPT (RAPT THERAPEUTICS INC) is held by 0 institutional investors as of Q1 2026.
0
Holders
Avg rating(6 Elite)
$0
Total Value
0% (50)
Fund Consensus
No verdict yet — fewer than 2 funds hold RAPT.
13F: Insider & Congress:
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $2.6M | 0.0% | +73.83% | 0 | |
Exited | 0(-100.0%) | $5.7M | 0.0% | +109.52% | 0 | |
Exited | 0(-100.0%) | $331,384 | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $424,222 | 0.0% | +117.96% | 0 | |
Exited | 0(-100.0%) | $21.7M | 0.0% | +54.55% | 0 | |
Exited | 0(-100.0%) | $64,223 | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $1.1M | 0.0% | +64.90% | 0 | |
Exited | 0(-100.0%) | $2M | 0.0% | +81.37% | 0 | |
Exited | 0(-100.0%) | $8.1M | 0.0% | -15.66% | 0 | |
Exited | 0(-100.0%) | $616,265 | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $832,254 | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $2.2M | 0.0% | +84.90% | 0 | |
Exited | 0(-100.0%) | $346,084 | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $1,000 | 0.0% | +560.23% | 0 | |
Exited | 0(-100.0%) | $14.4M | 0.0% | +77.66% | 0 | |
Exited | 0(-100.0%) | $16.5M | 0.0% | +96.01% | 0 | |
Exited | 0(-100.0%) | $55.5M | 0.0% | +285.80% | 0 | |
Exited | 0(-100.0%) | $392,892 | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $9.3M | 0.0% | +73.82% | 0 | |
Exited | 0(-100.0%) | $1.8M | 0.0% | +73.82% | 0 |
Showing 1-20 of 50
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer